• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. TRUE DILATATION CATHETER; BALLOON VALVULOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. TRUE DILATATION CATHETER; BALLOON VALVULOPLASTY CATHETER Back to Search Results
Catalog Number 0224512
Medical Device Problem Code Retraction Problem (1536)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
No medical records were provided to the manufacturer.A photo of the device was provided.The lot number for the device was provided.The device history records and device photo are currently under review.The return of the device is pending.The investigation is currently under way.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event or Problem Description
It was reported that post dilatation of a 26 mm tavi, during retraction through a 14 fr sheath, the valvuloplasty balloon allegedly would not retract into the sheath.It was further reported that the sheath and catheter were removed together as a single unit resulting in alleged trauma at the femoral artery access site, requiring additional balloon angioplasty to tamponade the resultant leak.Patient status was unknown.
 
Additional Manufacturer Narrative
A manufacturing review was performed.The lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.The device was not returned, however one electronic photo of the device was provided for review.Based on the bunching of the balloon material from the returned photo, the investigation can be confirmed for sheath-related retraction issues.The definitive root cause could not be determined based upon the available information.It is unknown if procedural issues contributed to the reported event.Following the initial retraction difficulty within the introducer sheath, it is unknown whether the balloon was placed in an anatomical position in which it could be safely inflated/deflated in an attempt to re-fold the balloon.Labeling review:the current instructions for use (ifu) states: warnings & precautions: never use force when advancing or retracting intravascular device without first angiographically determining cause for any resistance.Using force may damage catheter or cause injury to the patient (such as vessel perforation).Do not exceed maximum inflation pressure indicated on label.Excess inflation pressure can cause balloon rupture and the inability to withdraw catheter through introducer sheath.Withdrawing balloon through introducer sheath may damage balloon.Balloon deflation and catheter removal: deflate balloon by drawing vacuum on the = 50 cc inflation device.Use fluoroscopy to visually confirm that balloon has fully deflated prior to withdrawing catheter.While maintaining negative pressure and guidewire position, withdraw deflated device over the guidewire and out through introducer sheath.Use of a gentle clockwise twisting motion may be used to help withdraw balloon through introducer sheath.If unusual resistance is met when attempting to withdraw balloon, position balloon in anatomical position in which it can be inflated safely.Partially inflate balloon and then deflate it.Balloon re-folding can be observed under fluoroscopy.Use of recommended contrast concentration will facilitate fluoroscopic visualization of balloon re-folding.If balloon will not pass through introducer sheath for removal, remove balloon and sheath as a single unit.
 
Event or Problem Description
It was reported that post dilatation of a 26mm tavi, during retraction through a 14 fr sheath, the valvuloplasty balloon allegedly would not retract into the sheath.It was further reported that the sheath and catheter were removed together as a single unit resulting in alleged trauma at the femoral artery access site, requiring additional balloon angioplasty to tamponade the resultant leak.Patient status was unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRUE DILATATION CATHETER
Common Device Name
BALLOON VALVULOPLASTY CATHETER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
MDR Report Key7149104
Report Number2020394-2017-01814
Device Sequence Number1145259
Product Code OZT
UDI-Device Identifier00801741091001
UDI-Public(01)00801741091001
Combination Product (Y/N)N
Initial Reporter CountryUK
PMA/510(K) Number
K150667
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,distri
Initial Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date (Section B) 02/02/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/28/2020
Device Catalogue Number0224512
Device Lot NumberGFBU1076
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 12/01/2017
Supplement Date Received by Manufacturer01/19/2018
Initial Report FDA Received Date12/27/2017
Supplement Report FDA Received Date02/02/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-